These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 25380424)

  • 1. Novo sets sights on obesity market with diabetes drug.
    Sheridan C
    Nat Biotechnol; 2014 Nov; 32(11):1071-2. PubMed ID: 25380424
    [No Abstract]   [Full Text] [Related]  

  • 2. Liraglutide for Type 2 diabetes and obesity: a 2015 update.
    Iepsen EW; Torekov SS; Holst JJ
    Expert Rev Cardiovasc Ther; 2015; 13(7):753-67. PubMed ID: 26106933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treating with liraglutide an obese patient with type 2 diabetes mellitus and hereditary hemochromatosis.
    Tassone F; Baffoni C; Gianotti L; Pellegrino M; Magro G; Cesario F; Maccario M; Borretta G
    Minerva Endocrinol; 2015 Dec; 40(4):331-2. PubMed ID: 25801016
    [No Abstract]   [Full Text] [Related]  

  • 4. Novo Nordisk pays $58.7m to settle claims of mis-selling liraglutide.
    Dyer O
    BMJ; 2017 Sep; 358():j4214. PubMed ID: 28887314
    [No Abstract]   [Full Text] [Related]  

  • 5. New drugs: Liraglutide, dalfampridine, and abobotulinumtoxinA.
    Hussar DA; Kaczinski J
    J Am Pharm Assoc (2003); 2010; 50(3):436-9. PubMed ID: 20452924
    [No Abstract]   [Full Text] [Related]  

  • 6. Improved Glycemic Control and Vascular Function and Reduction of Abdominal Fat Accumulation with Liraglutide in a Case of Werner Syndrome with Diabetes Mellitus.
    Ide S; Yamamoto M; Takemoto M; Fujimoto M; Ide K; Kobayashi K; Yokote K
    J Am Geriatr Soc; 2016 Mar; 64(3):687-8. PubMed ID: 27000366
    [No Abstract]   [Full Text] [Related]  

  • 7. Liraglutide: A New Option for the Treatment of Obesity.
    Nuffer WA; Trujillo JM
    Pharmacotherapy; 2015 Oct; 35(10):926-34. PubMed ID: 26497479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycemic control and the heart: it matters how you get there.
    Bloomgarden Z
    J Diabetes; 2016 Jul; 8(4):453-4. PubMed ID: 26990043
    [No Abstract]   [Full Text] [Related]  

  • 9. Evaluating the safety of diabetes drugs: perspective of a Food and Drug Administration insider.
    Misbin RI
    Diabetes Care; 2005 Oct; 28(10):2573-6. PubMed ID: 16186303
    [No Abstract]   [Full Text] [Related]  

  • 10. The UGDP and the FDA audit.
    Am Fam Physician; 1979 Jul; 20(1):67. PubMed ID: 377929
    [No Abstract]   [Full Text] [Related]  

  • 11. Retrospective study comparing healthcare costs and utilization between commercially insured patients with type 2 diabetes mellitus who are newly initiating exenatide once weekly or liraglutide in the United States.
    Johnston SS; Nguyen H; Cappell K; Nelson JK; Chu BC; Kalsekar I
    J Med Econ; 2015; 18(9):666-77. PubMed ID: 25867133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Obesity in 2015: Advances in managing obesity.
    Dixon JB
    Nat Rev Endocrinol; 2016 Feb; 12(2):65-6. PubMed ID: 26729038
    [No Abstract]   [Full Text] [Related]  

  • 13. FDA upholds findings of UGDP study.
    JAMA; 1979 Jan; 241(1):17-8. PubMed ID: 758481
    [No Abstract]   [Full Text] [Related]  

  • 14. Diabetes drug may be associated with increase in risk of bladder cancer.
    Stephenson J
    JAMA; 2011 Jul; 306(2):143. PubMed ID: 21750286
    [No Abstract]   [Full Text] [Related]  

  • 15. Diabetes field cautiously upbeat despite possible setback for leading SGLT2 inhibitor.
    Jones D
    Nat Rev Drug Discov; 2011 Aug; 10(9):645-6. PubMed ID: 21878967
    [No Abstract]   [Full Text] [Related]  

  • 16. Oral antidiabetics: philosophy and politics.
    Bowen AJ
    J Med Assoc Ga; 1976 Nov; 65(11):411-4. PubMed ID: 993676
    [No Abstract]   [Full Text] [Related]  

  • 17. [The biguanides].
    Policlinico Prat; 1967 Oct; 74(40):1368-71. PubMed ID: 5605525
    [No Abstract]   [Full Text] [Related]  

  • 18. Diffusion into use of exenatide for glucose control in diabetes mellitus: a retrospective cohort study of a new therapy.
    Segal JB; Dy SM; Millman EA; Herbert R; Bass EB; Wu A
    Clin Ther; 2007 Aug; 29(8):1784-94. PubMed ID: 17919559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expert consensus on the use of liraglutide in the treatment of diabetes in internal medicine.
    Calvo Gómez C; Gómez-Huelgas R; Lima Ruiz J; Masmiquel Comas L; Michán Doña A; Zapatero Gaviria A
    Int J Clin Pharmacol Ther; 2016 Nov; 54(11):880-890. PubMed ID: 27487367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug safety. Planned study of Avandia in doubt after FDA review.
    Kean S
    Science; 2010 Jul; 329(5990):375. PubMed ID: 20651123
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.